These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 7041325

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
    van der Kaaden ME, Rijken DC, Groeneveld E, van Berkel TJ, Kuiper J.
    Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
    [Abstract] [Full Text] [Related]

  • 23. Immobilization of plasminogen activator, urokinase, on nylon.
    Sugitachi A, Takagi K, Imaoka S, Kosaki G.
    Thromb Haemost; 1978 Apr 30; 39(2):426-36. PubMed ID: 580991
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G, Noring R, Klempner MS.
    Biochem Biophys Res Commun; 1996 Feb 27; 219(3):690-5. PubMed ID: 8645243
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antithrombin III-independent effect of depolymerized holothurian glycosaminoglycan (DHG) on acute thromboembolism in mice.
    Nagase H, Kitazato KT, Sasaki E, Hattori M, Kitazato K, Saito H.
    Thromb Haemost; 1997 Feb 27; 77(2):399-402. PubMed ID: 9157603
    [Abstract] [Full Text] [Related]

  • 31. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M, D'Aprile AM, Italia A, Gresele P, Morser J, Semeraro N.
    Thromb Haemost; 2001 Apr 27; 85(4):661-6. PubMed ID: 11341502
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH, Diamond SL.
    J Clin Invest; 1995 Jun 27; 95(6):2483-90. PubMed ID: 7769094
    [Abstract] [Full Text] [Related]

  • 34. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro.
    Korninger C, Collen D.
    Thromb Haemost; 1981 Aug 28; 46(2):561-5. PubMed ID: 6795744
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The inhibition of high and low molecular weight urokinase in plasma.
    Murano G, Aronson D, Williams L, Brown L.
    Blood; 1980 Mar 28; 55(3):430-6. PubMed ID: 6444529
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.